ESSA Pharma Slides As Insider Purchases Lose Another US$211k

Simply Wall StNov 4 09:18 ET

ESSA Pharma Downgraded by Oppenheimer, Piper Sandler After Drug Setback in Trials

InvestingNov 4 08:06 ET · Ratings

Express News | ESSA Pharma Shares Are Trading Lower After Oppenheimer Downgraded the Stock From Outperform to Perform. Piper Sandler Downgraded Its Rating From Overweight to Neutral and Cut Its Price Target From $15 to $2

BenzingaNov 4 08:03 ET

Essa Pharma Price Target Cut to $2.00/Share From $15.00 by Piper Sandler

Dow JonesNov 4 07:07 ET · Ratings

Essa Pharma Cut to Perform From Outperform by Oppenheimer

Dow JonesNov 4 07:01 ET · Ratings

Oppenheimer Downgrades ESSA Pharma(EPIX.US) to Hold Rating

Moomoo NewsNov 4 05:33 ET · Ratings